PLA2R1 and membranous glomerulonephritis: Incomplete disease coverage: The T-cell paradigm primarily explains minimal change disease (MCD) pathogenesis but fails to account for antibody-mediated diseases like membranous nephropathy, where specific autoantibodies (anti-PLA2R, anti-THSD7A) are the primary pathogenic drivers (205, 206).